Riera*, J., Samuel*.C., Donatacci*. D., Duarte*. A., Osea*. J., and Coleman. N. Can NMDAR antagonists regulate Ras-GTP in cancer? The Posters on the Hill. Washington, DC, April 2019.

Riera*, J., Samuel*. C., Donatacci*. D., Duarte*. A., Osea*. J., and Coleman. N. Regulation of Ras-GTP in Solid Tumors by NMDA Receptor Antagonists. In Proceedings of the NJCU STEM Research Symposium. Jersey City, April 2018.

Samuel*. C., Riera*. J., Cabezas*. A., and Coleman. N. The Role of NMDA Receptors in Melanoma. In Proceedings of the NJCU STEM Research Symposium. Jersey City, April 2018. 2015. First place in poster competition.

Galarraga*. M., Donatacci*. D., Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. Understanding Blood Brain Barrier Integrity. The NJCU STEM Research Symposium. Jersey City, April 2017.

Donatacci*. D., Galarraga*. M., Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. New Prospective in the Treatment of Lung Cancer. The NJCU STEM Research Symposium. Jersey City, April 2017.

Chakraborty. A., Murphy. S., and Coleman. N. The Role of GluN2B/1 Receptor in the Modulation of Ras-Gtp in Neurofibromatosis Type 1. NYSCF Annual International Conference. New York City, October 2016.

Galarraga*. M., Donatacci*. D., Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. Consequence of Lead Toxicity in Blood Brain Barrier. The 49^th Annual Fall MACUB Conference. SUNI, Old Westbury, October 29^th, 2016.

Donatacci*. D., Galarraga*. M., Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. New Prospective in the Treatment of Lung Cancer. The 49^th Annual Fall MACUB Conference. SUNI, Old Westbury, October 29^th, 2016. First place in poster competition.

Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. Cellular and Molecular Mechanisms of Lead Toxicity in the Blood Brain Barrier. The NJCU STEM Research Symposium. Jersey City, April 2016. First place in poster competition.

Duarte*. A., Faltas*. C., Osea*. J., and Coleman. N. NMDA Receptors as a New Therapeutic Target for Cancer. The NJCU STEM Research Symposium. Jersey City, April 2016. First place in poster competition.

Faltas*. C., Duarte*. A., Osea*. J., and Coleman. N. “Lead Toxicity in the Blood Brain Barrier.” The 7^th Annual GS-LSAMP Phase II-NNJ-B2B STEM Research Conference. New Brunswick. NJ. October 2015. First place in poster competition.

Massett*. M, Youssef*. M., Ocea*. J., and Coleman. N. “Mathematical Model of Cancer Cell Viability After Different Regimens of Treatment with Doxorubicin”. The 48^th Annual Fall MACUB Conference. Montclair University, NJ. November, 2015. Third place in poster competition.

Duarte*. A., Faltas*. C., Osea*. J., and Coleman. N. “The Cellular and Molecular Role of NMDA Receptors in Cancer”. The 48^th Annual Fall MACUB Conference. Montclair University, NJ. November, 2015. Second place in poster competition.

Faltas*.C., Duarte*. A., Osea*. J. and Coleman. N. “Lead Toxicity in the Blood Brain Barrier.” The 48^th Annual Fall MACUB Conference. Montclair University, NJ. November, 2015.

Massett*. M., Youssef*. M., Ocea*. J., and Coleman. N. “Mathematical Model of Cancer Cell Viability After Different Regimens of Treatment with Doxorubicin”. NJCU STEM Symposium. NJCU. NJ. April, 2015. First place in poster competition.

Youssef*. M., Osea*. J., Llanos*. K., and Coleman. N. “The Role of NMDA Receptors in Cancer”. NJCU STEM Symposium. NJCU. NJ. April, 2015. First place in poster competition.

Youssef*. M., Osea*. J., Llanos*. K., and Coleman. N. “The Role of NMDA Receptors in Cancer”. The 47^th Annual Fall MACUB Conference. Molloy College, NY. November, 2014. Second place in poster competition.

Coleman. N., Llanos*. K., Osea*. J., Souverain*. R., Youssef*. M., and Coleman. N. “The Role of NMDA Receptors in cancer”. The 6^th Annual GS-LSAMP STEM Research Conference, New Brunswick. NJ. October 2014.

Racki*. J., Osea*. J., and Coleman. N. “Using Human Prostate Cancer Cell Line for Drug Target Identification”. Saint Peter’s Preparatory High School, Jersey City, NJ. 24 September 2014.

Coleman. N., Chakraborty. A., and Barald. K. “The Role of Neurofibromin in Stem Cell Differentiation”, International Society for Stem Cell Research, 12^th Annual Meeting, Vancouver, June 2014.

Farbaniec*. M., Chakraborty. A., Barald. K., and Coleman, “The Role of Neurofibromin in Stem Cell Differentiation”, AACR, Washington DC, April 2013.

Farbaniec*. M., Barald. K., and Coleman. N. “The Role of Neurofibromin in Stem Cell Differentiation”, The Stem Cell Research and Therapeutic Conference, Philadelphia, October 2012.

Farbaniec*. M., Homza*. L., Anand*. P., and Coleman. N. “Comparison of MTT and BrdU Assays to Examine the Cytotoxic Effects of Doxorubicin on the Human Carcinomas”, USciences Research Day, Philadelphia, April, 2012.

Farbaniec*. M., Barald. K., and Coleman. N. “The Role of Neurofibromin in Mouse Embryonic Stem Cell Differentiation”, USciences Research Day, Philadelphia, April, 2012.

Farbaniec*. M., Barald. K., and Coleman. N. “The Role of Neurofibromin in Mouse Embryonic Stem Cell Differentiation”, Sigma Xi Student Research Day at Thomas Jefferson University, Philadelphia, April, 2012.

Anand*. P., Martinez*. C., Galm*. K., and Coleman. N. “Comparison of MTT and BrdU Assays to Examine the Cytotoxic Effects of Doxorubicin on the Human Carcinomas”. Annual Meeting of the Mid-Atlantic Pharmacology Society (MAPS), Philadelphia, December 2010.

Martinez*. C., Gourevitch. D, Barald. K., Bui*. M. and Coleman. N. “The Role of NMDA Receptors in Embryonic Stem Cells with Different Levels of Neurofibromin Differentiation into Neural Cells”. Annual Meeting of the Mid-Atlantic Pharmacology Society (MAPS), Philadelphia, December 2010.

Alagoz. Z., Gaye*. B., Coleman. N., Wallach*. J., and Adejare. A. “Syntheses and Pharmacological Evaluations of Novel N-substituted bicycle-heptan-2-amines at NMDA Receptors”. American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, November 2010.

Z. Alagoz, M. Martin*, N. Coleman, A. Wan, and A. Adejare. “Design and Syntheses of Novel Radiosensitizer Analogs as Potent Anticancer Agents”. American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, November 2010.

C. Martinez*, P. Ramamurthy, Z. Alagoz, A. Adeniji, K. Barald, A. Adejare, N. Coleman. “Effects of Novel NMDA Receptor Antagonist on Mouse Embryonic Stem Cells Differentiation into Neuronal Cells”. American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, November 2010.

C. Martinez*, Z. Alagoz, A. Adeniji, A. Adejare, N. Coleman. “Effects of Novel NMDA Receptor Antagonists on Mouse Embryonic Stem Cells Differentiation into Neuronal Cells”. International Society for Stem Cell Research, 8^th Annual Meeting, San Francisco, June 2010.

M. Martin*, Z. Alagoz, N. Coleman, A. Wan, and A. Adejare. “In vitro Anticancer Properties of Novel Radiosensitizers”. USP Research Day, Philadelphia, Wednesday April 7th, 2010.

C. Martinez*, Z. Alagoz, A. Adeniji, A. Adejare, N. Coleman. “Effects of Novel NMDA Receptor Antagonists on Mouse Embryonic Stem Cells Differentiation into Neuronal Cells”. USP Research day, Philadelphia, April 2010.

M. Martin*, Z. Alagoz, N. Coleman, A. Wan, and A. Adejare. “In vitro Anticancer Properties of Novel Radiosensitizers”. Thomas Jefferson University Research Day, Philadelphia, Wednesday April 7th, 2010.

Z. Alagoz, N. Coleman, A. Wan, and A. Adejare. “Syntheses and In Vitro Anticancer Properties of Novel Radiosensitizer Analogs”. ACS Spring 2010 National Meeting & Exposition, San Francisco, March 2010.

C. Garnett*, K. Galm, A. Adejare, and N. Coleman. “Evaluation of MTT and BrdU Assays on Human Melanoma, Breast, and Prostate Cancer cell lines after Doxorubicin Treatment”. Annual Meeting of the Mid-Atlantic Pharmacology Society (MAPS), Temple University, Philadelphia, November 2009. First place at Poster Competition.

M. Martin*, Z. Ates-Alagoz, N. Coleman, A. Wan, and A. Adejare, “In vitro Anticancer Properties of Novel Radiosensitizer Analogs”, Annual Meeting of the Mid-Atlantic Pharmacology Society (MAPS), Temple University, Philadelphia, November 2009.

Z. Alagoz, N. Coleman, A. Adejare. “Syntheses and Pharmacological Evaluation of Novel NMDA Receptor Antagonists”. American Chemical Society National meeting & Exposition, Washington, DC, August 2009.

K. Galm*, A. Adejare, and N. Coleman. “Effects of Novel N-methyl-D-aspartate Receptor Antagonists on Neuronal Progenitor Cells”. USP research Day, Philadelphia, April 2009.

C. Garnett*, A. Adejare, and N. Coleman. “Evaluation of MTT and BrdU Assays on Human Melanoma (1205Lu) and Breast (MCF-7) Cancer Cell Lines After Doxorubicin Treatment”. USP Research day, Philadelphia, April 2009.

Z. Alagoz, N. Coleman, S. Sun*, and A. Adejare. “Pharmaceutical profiling of a novel NMDA receptor antagonists”. The J. Schwartz Memorial Symposium: Advances in industrial Pharmacy, USP Research day, Philadelphia, March 2009.

N. Coleman, A. Adejare, “Effects of novel N-methyl-D-aspartate receptor antagonists on neural progenitor cell”, International Society for Stem Cell Research Annual Meeting, Philadelphia, June 2008.

N. Coleman, A. Wan, K.E. Meachem, and A. Adejare, “In Vitro Cytotoxicity of a Novel NMDA receptor antagonist”, American Association of Pharmaceutical Scientists Annual Meeting, Atlanta, November 2008.

N. Coleman, K.E. Meachem, and A. Adejare, “In Vitro Toxicity Study of Novel Neuro-Protective Agents”, American Association of Pharmaceutical Scientists Annual Meeting, San Diego, November 2007.

N. Coleman, K.E. Meachem and A. Adejare, “In Vitro Toxicity Study of Novel Neuro-Protective Agents”, Mid-Atlantic Pharmacological Society Meeting, Philadelphia, October 2007.

T.I. Kuzmina, N. Coleman. Parthenogenic Development of in Vitro-Matured Bovine Oocytes. 8^th Baltic animal breeding and genetics conference. Kaunas, 2002:40.

N. Zabelina (Coleman), A.K. Golubev, T.I. Kuzmina, G.A. Shagiakhmetova. In Vitro Maturation and Early Development Capacity of Bovine Oocytes Cultured in Pure Follicular Fluid Depending on Its Heat Treatment at 56o C. Kiev University Press. Kiev, 1999:79-80.

N. Zabelina (Coleman), A.K. Golubev, T.I. Kuzmina, G.A. Shagiakhmetova. Caryological Abnormalities in Bovine Embryos Obtained from Oocytes in Vitro Matured in Homologous Follicular Fluid. Proceeding of the Scientific Conference “Improvement of Breeding and Production Characteristics of Agricultural Animal and Birds”. Moscow, 1999:100.

N. Zabelina (Coleman), A.K. Golubev, T.I. Kuzmina, G.A. Shagiakhmetova. In Vitro Maturation And Early Development Capacity of Bovine Oocytes Cultured in Pure Follicular Fluid Depending on Its Heat Treatment at 100o C. Proceeding of the Scientific Conference “The problems of the individual development of the agricultural animal”. Kiev, 1997:105-106.

T.I. Kuzmina, N. Zabelina (Coleman). Ca²⁺ Osciltions During the Maturation of Bovine Oocytes in Different Culture Systems. Arch. Tierz. Dummerstorf 39 Special Issue. Germany, 1996:81.

50. T.I. Kuzmina, T.E. Pozdnyakova*, G.A. Shagiakhmetova*, N. Zabelina (Coleman). Caryological Abnormalities in Bovine Embryos Obtained from in Vitro Matured Oocytes. Proceeding of the International Scientific Conference. Borovsk, 1995:195.

A.K. Golubev, N. Zabelina (Coleman), T.I. Kuzmina, G.A. Shagiakhmetova*. Bovine Oocyte Maturation in Homologous Follicular Fluid. Proceeding of the International Scientific Conference. Borovsk, 1995:176.

N. Zabelina (Coleman). In Vitro Maturation of Bovine Oocytes in Homologous Follicular Fluid. Abstract thesis for Ph.D. in Biological Sciences. St. Petersburg Agrarian University Press. St. Petersburg, 1995: 23.

T.I. Kuzmina, G.A. Shagiakhmetova*, N. Zabelina (Coleman). Cytomorphological Characteristics of Bovine Embryo Obtained from in Vitro Matured and Fertilized Oocytes. Proceeding of All-Ukrainian Anniversary Scientific Conference. Kiev, 1994:63.

T.E. Pozdnyakova, N. Zabelina (Coleman). Improvement of Bovine Maturation System for the Purposes of in Vitro Fertilization. Proceeding of the 1^st International Conference of Young Scientists and Specialists. Kiev, 1994:73.